About this site
A price-and-trust reference for compounded tirzepatide, published by Ronika Partners LLC.
What this site does
Affordable Tirzepatide Guide compares what compounded tirzepatide telehealth programs actually cost. We read the published plan pages, record the observed price with a date, separate starter prices from ongoing and highest-dose prices, add membership, lab and shipping fees, and show the 12-month total at a maintenance dose. We also maintain a dated FDA status page, because the rules around compounded GLP-1 drugs change faster than most comparison sites update.
We do not sell medication, prescribe, or dispense. Compounded tirzepatide is not FDA-approved and is not Zepbound® or Mounjaro®; that sentence appears on every page because it is the fact most often lost in marketing.
Who publishes it
The site is published by Ronika Partners LLC and is affiliate-supported: links marked “Sponsored” may earn a commission at no cost to you. How that is kept away from the findings is set out in the editorial and medical review policy and the advertising disclosure.
Team
Eduard Cristea
Editor
Writes and maintains the pricing comparisons, provider reviews and cost guides; runs the price verification cadence.
Dr. A. Goher, MD
Medical Reviewer
Reviews clinical statements against FDA labeling and published trials. Has no role in rankings or pricing.
How to reach us
Corrections and provider updates: corrections@affordablecompoundedtirzepatide.com (what to include). Reported errors are reviewed within 5 business days; confirmed material price errors are corrected within 2 business days.
Data and tools we publish
- Price index and cost hub with a change log and machine-readable data (nexlife-pricing-2026.json).
- Total-cost calculator with editable inputs and visible formulas.
- Pharmacy verification guide.
- llms.txt summary for AI systems.